Persistent Asset Partners Ltd Sells 81,140 Shares of Enhabit, Inc. $EHAB

Persistent Asset Partners Ltd lessened its holdings in shares of Enhabit, Inc. (NYSE:EHAB) by 28.3% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 205,983 shares of the company’s stock after selling 81,140 shares during the period. Enhabit comprises approximately 1.5% of Persistent Asset Partners Ltd’s holdings, making the stock its 15th largest holding. Persistent Asset Partners Ltd’s holdings in Enhabit were worth $1,986,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of EHAB. Jones Financial Companies Lllp grew its position in shares of Enhabit by 110,987.5% in the 1st quarter. Jones Financial Companies Lllp now owns 8,887 shares of the company’s stock worth $78,000 after buying an additional 8,879 shares during the last quarter. Strs Ohio purchased a new stake in Enhabit in the first quarter worth $82,000. CWM LLC boosted its holdings in Enhabit by 383.6% in the first quarter. CWM LLC now owns 11,738 shares of the company’s stock valued at $103,000 after acquiring an additional 9,311 shares in the last quarter. Acadian Asset Management LLC purchased a new position in Enhabit during the 1st quarter valued at $114,000. Finally, Mackenzie Financial Corp increased its position in Enhabit by 12.1% during the 1st quarter. Mackenzie Financial Corp now owns 14,468 shares of the company’s stock valued at $127,000 after purchasing an additional 1,564 shares during the period.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on EHAB shares. UBS Group cut their target price on shares of Enhabit from $10.00 to $8.50 and set a “neutral” rating on the stock in a research note on Friday, August 8th. Weiss Ratings reissued a “sell (e+)” rating on shares of Enhabit in a research note on Thursday. One investment analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Enhabit currently has a consensus rating of “Hold” and a consensus target price of $8.67.

Enhabit Stock Performance

Enhabit stock opened at $8.12 on Friday. Enhabit, Inc. has a twelve month low of $6.47 and a twelve month high of $10.90. The company has a quick ratio of 1.58, a current ratio of 1.58 and a debt-to-equity ratio of 0.75. The company has a market capitalization of $410.70 million, a P/E ratio of -32.46 and a beta of 1.69. The stock’s 50 day moving average is $8.11 and its 200 day moving average is $8.39.

Enhabit (NYSE:EHAB) last released its earnings results on Wednesday, November 5th. The company reported $0.17 EPS for the quarter, topping the consensus estimate of $0.12 by $0.05. Enhabit had a positive return on equity of 3.91% and a negative net margin of 1.14%.The business had revenue of $263.60 million for the quarter, compared to the consensus estimate of $267.08 million. Enhabit has set its FY 2025 guidance at 0.500-0.560 EPS. On average, equities research analysts predict that Enhabit, Inc. will post 0.22 earnings per share for the current fiscal year.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.